Home - Boston Life Sciences Times

LATEST ARTICLES

Biotech

New England Biolabs and Color Partner to Provide COVID-19 Testing to Biotech Workers Essential to Global Pandemic Response

Life Sciences Times - February 2, 20210

Medtech

Dr. Siddhartha Kadia to Join NuVasive Board of Directors

Life Sciences Times - February 2, 20210

Life Sciences

Life Biosciences appoints Joan Mannick, MD, to lead its research and development

Life Sciences Times - February 2, 20210

Life Sciences

MYND Life Sciences Announces Research Agreement with the University of British Columbia on Major Depressive Disorder

Life Sciences Times - February 2, 20210

Public Health

Bleeding gums may indicate vitamin C deficiency

Life Sciences Times - February 2, 20210

Public Health

56.13% of people in Delhi developed antibodies

Life Sciences Times - February 2, 20210

Pharma

Pfizer-BioNTech to produce 2 billion doses of Covid vaccine in 2021

Life Sciences Times - February 2, 20210

Life Sciences

Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China

Life Sciences Times - February 1, 20210

Pharma

Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial

Life Sciences Times - February 1, 20210

Pharma

Fractyl Announces Publication of Clinical Results from INSPIRE Study Showing Durable Insulin-Free Glycemic Control in Majority of Patients Treated

Life Sciences Times - February 1, 20210

1...869870871...890 Page 870 of 890

Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis

August 18, 2026

Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer

August 18, 2026

Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline

August 18, 2026

Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs

August 18, 2026

Most Popular

Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis

Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer

Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline

Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs

Recent Comments

EDITOR PICKS

Amylyx Reports Positive Phase 3 Results for Avexitide in Post-Bariatric Hypoglycemia

Zai Lab, argenx Report Positive Phase 3 Results for Efgartigimod in Autoimmune Myositis

FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Disease Evaluation

THIS WEEK'S STORIES

Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline

athenahealth Expands AI-Native athenaOne Tools to More Than 170,000 Clinicians

Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs

POPULAR CATEGORY

ABOUT US

FOLLOW US